Anemia in Renal Failure (AKB-6548-CI-0017)

When kidneys are diseased or damaged, they do not make enough EPO, a hormone produced by the kidney which aids in the production and formation of red blood cells in bone marrow. The bone marrow then makes fewer red blood cells, causing anemia.

AKB-6548-CI-0017 is a multicenter, randomized, open-label, active-controlled Phase 3 study for the maintenance treatment of anemia in subjects with Dialysis-Dependent Chronic Kidney Disease (DD-CKD)

Register Today!

Trial Information

Start DateAugust 2016
End DateJanuary 2020
Trial Duration4 years
Number of Visits33
Lead CRCSuzanne Fleming

For additional information
on this trial contact: